Dr. Cheng-Ho Jimmy Lin will deliver the 2017 Beimfohr Lecture March 1 at 8 p.m. Lin is the Chief Scientific Officer of oncology at Natera, where he is leading the development of new diagnostic technologies for cancer. Prior to this, he led the clinical genomics program at the National Cancer Institute (NCI) at the NIH as well as working on pioneering research at Johns Hopkins and Washington University in St. Louis. He has published in top academic journals, such as Science, Nature, and Cell, and has been featured in media outlets, such as New York Times, Forbes, Bloomberg Businessweek, Washington Post, and the Financial Times.